Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel
NASDAQ:INMD

InMode Q3 2026 Earnings Report

InMode logo
$14.13 -0.09 (-0.60%)
As of 10:19 AM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

InMode EPS Results

Actual EPS
N/A
Consensus EPS
$0.32
Beat/Miss
N/A
One Year Ago EPS
N/A

InMode Revenue Results

Actual Revenue
N/A
Expected Revenue
$91.59 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

InMode Announcement Details

Quarter
Q3 2026
Date
10/28/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

InMode Earnings Headlines

Reviewing InMode (NASDAQ:INMD) & Medline (NASDAQ:MDLN)
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31068491
Sintx Technologies (NASDAQ:SINT) and InMode (NASDAQ:INMD) Financial Comparison
September 27 at 2:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31053962
"How Much Can I Actually Spend Each Year With $2.5M Saved?"
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you make with it. Using the 4% rule as a benchmark, that balance could translate to about $100,000 in year one, adjusted upward for inflation each year after. But the 4% rule has potential downsides and may not fit every portfolio. A financial advisor can help size and structure a retirement budget around your income sources, taxes, and goals. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors.tc pixel
September 30 at 1:00 AM  |  SmartAsset (Ad)
InMode (NASDAQ:INMD) Stock Price Passes Above Two Hundred Day Moving Average - Here's Why
September 22, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31038423
InMode: Reasonably Valued But With Too Much Drama
September 16, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946975-inmode-reasonably-valued-but-with-too-much-drama
InMode Says Unsolicited Takeover Proposal Expires Without Deal
September 16, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/inmode-says-unsolicited-takeover-proposal-expires-without-deal?utm_source=marketbeat.com&utm_medium=referral
See More InMode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like InMode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on InMode and other key companies, straight to your email.

About InMode

InMode (NASDAQ:INMD) (NASDAQ: INMD) is an Israel-based medical technology company that develops, manufactures and markets energy-based platforms for minimally invasive and non-invasive aesthetic and medical treatments. Its technologies are designed for use by physicians and other healthcare professionals in areas including facial rejuvenation, skin resurfacing, body contouring, hair removal and women’s health.

The company’s product portfolio includes radiofrequency-based systems such as BodyTite and FaceTite for tissue remodeling and contouring, Morpheus8 for fractional skin treatment, and multi-application platforms such as EmpowerRF and Optimas. InMode sells its systems and related consumables primarily through a direct sales force and distributors to medical practices, clinics and hospitals.

Founded in 2008 and headquartered in Yokneam, Israel, InMode serves customers across North America, Europe, Asia-Pacific, Latin America and other international markets. The company completed its initial public offering on the Nasdaq stock exchange in 2019. Moshe Mizrahy, a co-founder of InMode, serves as the company’s chief executive officer and chairman.

View InMode Profile
Earnings Tools